A Randomized, Double-blind Controlled Study to Determine the Effectiveness, Safety and Tolerability of Actovex Compared to Avonex in Subjects with Relapsing Remitting Multiple Sclerosis (RRMS)
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Actover Pharmaceutical
Most Recent Events
- 02 Jul 2014 According to Iranian Registry of Clinical Trials, recruitment is expected to complete on 21 July 2015.
- 02 Jul 2014 New trial record